jueves, 18 de agosto de 2022

NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies | NIH: National Institute of Allergy and Infectious Diseases

NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies | NIH: National Institute of Allergy and Infectious Diseases

No hay comentarios:

Publicar un comentario